c-Met/HGFR
c-Met/HGFR inhibitors target the Hepatocyte Growth Factor Receptor (c-Met), a tyrosine kinase involved in cellular processes such as growth, motility, and morphogenesis. c-Met signaling is implicated in cancer progression, metastasis, and resistance to therapies. Inhibiting c-Met can disrupt tumor growth and spread, making these inhibitors valuable in cancer research. At CymitQuimica, we offer c-Met/HGFR inhibitors to support your research in oncology, metastasis, and targeted cancer therapies.
Read more
Savolitinib
CAS:1313725-88-0
Savolitinib (Volitinib) (AZD-6094) is an effective, selective, and orally bioavailable c-Met inhibitor (IC50s: 5 nM/3 …
Formula:
C17H15N9
Purity:
98.03%
Color and Shape:
Solid
Molecular weight:
345.36
Ref: TM-TQ0210
| 1mg | 49.00 € | ||
| 2mg | 63.00 € | ||
| 5mg | 90.00 € | ||
| 10mg | 129.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 366.00 € | ||
| 100mg | 555.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Capmatinib xHCl
CAS:1029714-89-3
Capmatinib xHCl (INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor, …
Formula:
C23H18ClFN6O
Purity:
99.12% - 99.24%
Color and Shape:
Solid
Molecular weight:
448.89
Ref: TM-T8416
| 1mg | 43.00 € | ||
| 2mg | 55.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 104.00 € | ||
| 25mg | 180.00 € | ||
| 50mg | 271.00 € | ||
| 100mg | 406.00 € | ||
| 500mg | 917.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
SRI 31215 TFA
CAS:1832686-44-8
SRI 31215 TFA acts as a triplex inhibitor of matriptase, hepsin and HGFA and mimics …
Formula:
C27H34F3N5O3
Purity:
98.25% - 99.97%
Color and Shape:
Solid
Molecular weight:
533.6
Ref: TM-T5478
| 1mg | 42.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 131.00 € | ||
| 25mg | 254.00 € | ||
| 50mg | 381.00 € | ||
| 100mg | 542.00 € | ||
| 200mg | 733.00 € | ||
| 1mL*10mM (DMSO) | 99.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Cabozantinib
CAS:849217-68-1
Cabozantinib (XL184) is a multi-targeted tyrosine kinase receptor inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, …
Formula:
C28H24FN3O5
Purity:
99.59% - 99.88%
Color and Shape:
Solid
Molecular weight:
501.51
Ref: TM-T2586
| 5mg | 46.00 € | ||
| 10mg | 59.00 € | ||
| 50mg | 78.00 € | ||
| 100mg | 94.00 € | ||
| 200mg | 150.00 € | ||
| 500mg | 244.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Capmatinib
CAS:1029712-80-8
Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential antineoplastic activity.
Formula:
C23H17FN6O
Purity:
99.24%
Color and Shape:
Solid
Molecular weight:
412.42
Ref: TM-T1963
| 5mg | 51.00 € | ||
| 10mg | 66.00 € | ||
| 25mg | 81.00 € | ||
| 50mg | 94.00 € | ||
| 100mg | 128.00 € | ||
| 200mg | 163.00 € | ||
| 500mg | 263.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Afatinib Dimaleate
CAS:850140-73-7
Afatinib Dimaleate (BIBW 2992MA2) is an orally bioavailable anilino-quinazoline derivative and inhibitor of the EGFR …
Formula:
C32H33ClFN5O11
Purity:
100% - 99.66%
Color and Shape:
Solid
Molecular weight:
718.08
Ref: TM-T1773
| 1g | 460.00 € | ||
| 5mg | 40.00 € | ||
| 10mg | 58.00 € | ||
| 25mg | 85.00 € | ||
| 50mg | 105.00 € | ||
| 100mg | 138.00 € | ||
| 200mg | 184.00 € | ||
| 500mg | 308.00 € | ||
| 1mL*10mM (DMSO) | 66.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
c-Kit-IN-1
CAS:1225278-16-9
c-Kit-IN-1 (DCC-2618) is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
Formula:
C26H21F2N5O3
Purity:
98.16% - 98.72%
Color and Shape:
Solid
Molecular weight:
489.47
Ref: TM-T4332
| 1mg | 45.00 € | ||
| 2mg | 59.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 143.00 € | ||
| 25mg | 301.00 € | ||
| 50mg | 536.00 € | ||
| 100mg | 768.00 € | ||
| 500mg | 1,568.00 € | ||
| 1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
X-376
CAS:1365267-27-1
X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase ALK …
Formula:
C25H25Cl2FN6O3
Purity:
98.72%
Color and Shape:
Solid
Molecular weight:
547.41
Ref: TM-T3550
| 1mg | 35.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 255.00 € | ||
| 50mg | 422.00 € | ||
| 100mg | 574.00 € | ||
| 1mL*10mM (DMSO) | 104.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
BMS817378
CAS:1174161-69-3
BMS817378 is a potent and selective inhibitor of MET(IC50 : 1.7 nM).
Formula:
C24H18ClF2N4O7P
Purity:
100%
Color and Shape:
Solid
Molecular weight:
578.85
Ref: TM-T7787
| 1mg | 91.00 € | ||
| 2mg | 114.00 € | ||
| 5mg | 167.00 € | ||
| 10mg | 241.00 € | ||
| 25mg | 438.00 € | ||
| 50mg | 642.00 € | ||
| 100mg | 915.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Ensartinib hydrochloride
CAS:2137030-98-7
Ensartinib hydrochloride (X-396 dihydrochloride) is a potent new-generation ALK inhibitor with high activity against CNS …
Formula:
C26H29Cl4FN6O3
Purity:
98.73%
Color and Shape:
Solid
Molecular weight:
634.36
Ref: TM-T22324
| 1mg | 65.00 € | ||
| 2mg | 91.00 € | ||
| 5mg | 142.00 € | ||
| 10mg | 223.00 € | ||
| 25mg | 453.00 € | ||
| 50mg | 664.00 € | ||
| 100mg | 917.00 € | ||
| 1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Glumetinib
CAS:1642581-63-2
Glumetinib (SCC244) (SCC 244) is a novel potent and selective inhibitor of c-Met kinase (IC50: …
Formula:
C21H17N9O2S
Purity:
100%
Color and Shape:
Solid
Molecular weight:
459.48
Ref: TM-T5414
| 1mg | 54.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 167.00 € | ||
| 25mg | 272.00 € | ||
| 50mg | 407.00 € | ||
| 100mg | 600.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Hepln-13
CAS:64369-13-7
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
Formula:
C17H13BrN2
Purity:
97.67%
Color and Shape:
Solid
Molecular weight:
325.2
Ref: TM-T25492
| 1mg | 37.00 € | ||
| 2mg | 49.00 € | ||
| 5mg | 82.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 236.00 € | ||
| 50mg | 351.00 € | ||
| 100mg | 488.00 € | ||
| 200mg | 675.00 € | ||
| 1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Altiratinib
CAS:1345847-93-9
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block …
Formula:
C26H21F3N4O4
Purity:
98.98% - 99.39%
Color and Shape:
Solid
Molecular weight:
510.46
Ref: TM-T2054
| 5mg | 52.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 135.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 313.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
NVP-BVU972
CAS:1185763-69-2
NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM.
Formula:
C20H16N6
Purity:
100% - 98.61%
Color and Shape:
Solid
Molecular weight:
340.38
Ref: TM-T2680
| 1mg | 47.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 291.00 € | ||
| 50mg | 414.00 € | ||
| 100mg | 584.00 € | ||
| 1mL*10mM (DMSO) | 121.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
BMS 777607
CAS:1025720-94-8
BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3. BMS-777607 has been investigated for …
Formula:
C25H19ClF2N4O4
Purity:
100% - 99.89%
Color and Shape:
Solid
Molecular weight:
512.89
Ref: TM-T2699
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 213.00 € | ||
| 50mg | 351.00 € | ||
| 100mg | 522.00 € | ||
| 500mg | 1,154.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
MK-8033
CAS:1001917-37-8
MK-8033 is a new and selective dual ATP competitive c-Met/Ron inhibitor (IC50: 1 nM Wt …
Formula:
C25H21N5O3S
Purity:
97.16%
Color and Shape:
Solid
Molecular weight:
471.53
Ref: TM-TQ0219
| 1mg | 95.00 € | ||
| 2mg | 140.00 € | ||
| 5mg | 231.00 € | ||
| 10mg | 394.00 € | ||
| 25mg | 644.00 € | ||
| 50mg | 914.00 € | ||
| 1mL*10mM (DMSO) | 242.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Herbacetin
CAS:527-95-7
1.
Formula:
C15H10O7
Purity:
96.89% - 99.51%
Color and Shape:
Solid
Molecular weight:
302.24
Ref: TM-T5S1331
| 1mg | 46.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 142.00 € | ||
| 25mg | 290.00 € | ||
| 50mg | 438.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Golvatinib
CAS:928037-13-2
Golvatinib (E-7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) …
Formula:
C33H37F2N7O4
Purity:
98.24% - ≥95%
Color and Shape:
Solid
Molecular weight:
633.69
Ref: TM-T6517
| 2mg | 45.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 91.00 € | ||
| 25mg | 155.00 € | ||
| 50mg | 195.00 € | ||
| 100mg | 347.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
AMG-337
CAS:1173699-31-4
AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337 …
Formula:
C23H22FN7O3
Purity:
99.82% - 99.9%
Color and Shape:
Solid
Molecular weight:
463.46
Ref: TM-T3209
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 84.00 € | ||
| 10mg | 123.00 € | ||
| 25mg | 195.00 € | ||
| 50mg | 347.00 € | ||
| 100mg | 515.00 € | ||
| 200mg | 739.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Capmatinib 2HCl.H2O
CAS:1865733-40-9
Capmatinib 2HCl.H2O (NVP-INC280 2HCl.H2O) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential …
Formula:
C23H21Cl2FN6O2
Purity:
99.84%
Color and Shape:
Solid
Molecular weight:
503.36
Ref: TM-T8825
| 5mg | 49.00 € | ||
| 10mg | 68.00 € | ||
| 25mg | 113.00 € | ||
| 50mg | 174.00 € | ||
| 100mg | 278.00 € | ||
| 500mg | 580.00 € | ||
| 1mL*10mM (DMSO) | 82.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
